NCT03651453

OPTIONS: A Patient-Centered HIV Prevention Decision Aid for PrEP Uptake for Women With Substance Use in Treatment Settings

Developing and Testing the Effect of a Patient-Centered HIV Prevention Decision Aid on PrEP Uptake for Women With Substance Use in Treatment Settings

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 164 (actual)
• Sponsor: Yale University · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

To develop and test the effect of a patient-centered HIV prevention decision aid on HIV pre-exposure prophylaxis (PrEP) uptake among women with substance use disorders (SUD) in treatment.

Detailed description

To test the effect of the informed decision aid intervention on PrEP uptake among women with substance use disorders in treatment. Investigators hypothesize that compared to those receiving standard harm reduction information, women receiving the decision aid will have a significant increase in PrEP uptake at 6 and 12 months post-intervention.

Conditions

• HIV Infections
• Substance Abuse

Interventions

Type	Name	Description
BEHAVIORAL	Decision aid	Participants in the experimental arm will receive the PrEP decision aid.
BEHAVIORAL	Standard care	Standard harm reduction information

Timeline

• Start date: 2018-10-15
• Primary completion: 2020-06-11
• Completion: 2020-06-11
• First posted: 2018-08-29
• Last updated: 2021-07-28

Locations

1 site across 1 country: United States